|
Volumn 7, Issue 6, 2005, Pages R1153-R1158
|
Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ESTROGEN RECEPTOR;
TAMOXIFEN;
ADULT;
AGED;
ANTAGONISTS AND INHIBITORS;
BREAST NEOPLASMS;
CELL TRANSFORMATION;
CHEMICALLY INDUCED;
CHEMOPROPHYLAXIS;
DRUG EFFECTS;
FEMALE;
GENETIC PREDISPOSITION;
GENETICS;
HUMAN;
INCIDENCE;
MIDDLE AGED;
OVARIECTOMY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RISK FACTOR;
SECOND CANCER;
TUMOR SUPPRESSOR GENE;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CELL TRANSFORMATION, NEOPLASTIC;
CHEMOPREVENTION;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
INCIDENCE;
MIDDLE AGED;
NEOPLASMS, SECOND PRIMARY;
OVARIECTOMY;
RECEPTORS, ESTROGEN;
RISK FACTORS;
TAMOXIFEN;
|
EID: 38449093602
PISSN: None
EISSN: 1465542X
Source Type: Journal
DOI: 10.1186/bcr1342 Document Type: Article |
Times cited : (12)
|
References (0)
|